基因總覽
ST6GAL1 是蛋白質編碼基因,其產物為 ST6 beta-galactoside alpha-2,6-sialyltransferase 1,屬於 glycosyltransferase 29 家族。這是一種單次穿膜的第二型膜蛋白,具有短的細胞質端、跨膜區段與較長的腔內區域。蛋白質主要以高基氏體膜上的膜結合形式存在,也有分泌至體液中的形式。其基本角色是催化醣鏈修飾,為細胞表面分子及其他蛋白質上的醣鏈添加唾液酸。
基因異名與舊稱
異名取自 HGNC,可能包含歷史名稱;蛋白質名稱以 UniProt 註解為準。
染色體位置與基因結構
查看實際轉錄本與 exon 註解
| Transcript | Genomic coordinates | Exons |
|---|---|---|
| ENST00000169298 ★ | 186,930,526–187,078,553 | 8 |
| ENST00000879710 | 186,930,343–187,078,932 | 10 |
| ENST00000879713 | 186,930,356–187,078,932 | 8 |
| ENST00000955782 | 186,930,356–187,078,932 | 10 |
| ENST00000955784 | 186,930,356–187,078,932 | 9 |
| ENST00000677292 | 186,930,466–187,078,932 | 10 |
| ENST00000879711 | 186,930,466–187,078,932 | 9 |
| ENST00000879712 | 186,930,466–187,078,932 | 9 |
| ENST00000879714 | 186,930,466–187,078,932 | 9 |
| ENST00000879715 | 186,930,466–187,078,932 | 9 |
| ENST00000879716 | 186,930,466–187,078,932 | 7 |
| ENST00000879717 | 186,930,466–187,078,932 | 9 |
顯示 12/65 個蛋白質編碼轉錄本;canonical 優先。
帶型與著絲點依 Ensembl 座標繪製;核染色體長度以 GRCh38 第 1 號染色體為共同尺度。黃色標記表示本基因位置,細小區間加粗以利辨識;實際基因長度與 exon 見下方資料。
分子功能與生物學過程
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 將唾液酸由 CMP-sialic acid 轉移至含半乳糖的受體分子,形成 alpha-2,6 鍵結的唾液酸化產物。此反應可作用於不同的醣鏈受體,包含蛋白質上的複合型 N-醣鏈;其催化反應伴隨 CMP 釋出。這類醣基轉移作用屬於蛋白質修飾與蛋白質醣基化的一環。
在 B 淋巴球中,ST6GAL1 參與生成對 neuraminidase 敏感的淋巴球細胞表面分化抗原,例如 CDw75、HB-6 與 CD76。這些例子顯示,該酵素對細胞表面分子醣鏈的修飾,與淋巴球表面抗原的形成有關。
另一類受體是 IgG 的 fragment crystallizable(Fc)區所連接的複合型 N-醣鏈。ST6GAL1 可使這些醣鏈唾液酸化;來源指出,這種修飾可賦予 IgG 抗發炎效應功能。對 Fc 醣鏈而言,酵素優先在 alpha(1->3) mannose 分枝上添加一個唾液酸,形成單唾液酸化產物;後續再加上第二個唾液酸、形成雙唾液酸化的速度則慢得多。
其受體範圍也包括具有不同分枝與修飾形式的蛋白質 N-醣鏈。來源列出的反應涵蓋已帶有唾液酸或尚未唾液酸化的分枝,以及含或不含特定 N-乙醯葡萄糖胺、半乳糖與岩藻糖結構的醣鏈,顯示 ST6GAL1 能在多種複合型 N-醣鏈上催化 alpha-2,6 唾液酸化。這些反應共同說明,ST6GAL1 透過改變細胞表面抗原與蛋白質醣鏈的末端結構,參與醣鏈修飾及其相關功能。
Promoter 與基因調控
>ST6GAL1 ENST00000169298 GRCh38 chr3:186929526-186930626 strand=1 5′→3′ 相對 TSS:-1000 到 +100 bp;1101 bp 依轉錄本 TSS 擷取的基因組序列;TSS = 0,兩端包含,未驗證為 promoter TGTGGGGTAGGCACCTCATTTGGAGACAGAACTCTGGGCCTGGGCTTCAGGCACTTTAAGTGTGCACTGG ACTTTGTGTTCCCAGAGGACCCCCAAACCTTCCAGTATCTCCTTCCTTTCCCCTTTCCCACCCAGCACAC AGCCTGGTGCCTAGTGTGCACTCAGTAGACAACTGGGATATGACTATTGCCTCTGGTAGTCACATCCTCT CTTTGGGCTATGGGAGGCTGGACTGGAGGCCTTAAAGGCCCCTTCCGCCCTCCTGTTGGGCAGTTTTTCT TTCTTAGGGAAATCGCCTTGGGGCTATCGGGGATGGTCAGTACGCAGCTTGGTTAATCCTCTTTCCTTCC CCAGCAGCCCCACCGTCGTCCGGGTGAAAAGAAAGAACCTCGCTCCCTTCACCATCCAGGCTGAGGCTTC AGTCTTTCAGCCTGCAGCTTGGGGTGGAAGCCTCTGGGTGCAGGGGTTCGAGGACGCTCCTCTCCTTCTG TATTTGCCATTTGAGAGCGCCCAGTAGGAGTCATGCCTCAATGTTAGGAGGTTAATGCCAAACGCAGTGA AAGATTTTGTTCTTTCCTATTCTAGATAAGAGCAACACGAGTCTTCGGAGAGGTTAAGCGACTTCCTCAG GGTCTCGCAGTCAGCCGGTAGCAGAGACCGGGTGTACAGCACCCGCATGTTAGGACCAAAAGCCGGACAC TGCTGGATTGACCCCTCGCGGCCAAGCGGGGAAGAGGCATTTAGGGGTCCTTGCGCAGCCGCGTGGCCCC TCCCACTCGGCCCTCGATCCACCCTCCTTGAGAGCAGGCAGGATTCTAGCATCACCCAGTGCCTTCATCA AGAGTCTTTAACCCCAAGCCCGCTCGCTAGCGACCTCCAGGCCGGTTTGGGGCGCGGTGTGGCCGGTGGC GAGAGGTGGAGTGGGGGCGGAGACCGACCCAGTCTTCGCAACTCTATTTGCATACGGAGGCGACTCGCTT CCTTCCCGCCCCTCCGCCGCGCTCTTCTTCCTTCCTTCTCCAGTCCCTTCCACTGTGCGTCTTCTGTCCC CCGTTCTTCCCCAGCGGACCCCTCTTTCGAGACTCCCTAGTGGGGTCCCCA
EPDnew 實驗支持 promoter/TSS · 3 筆
| EPDnew ID | TSS(1-based) | 股向 | 來源顯示區間 |
|---|---|---|---|
| ST6GAL1_1 ↗ | 3:186,930,526 | 正股 | 186,930,477–186,930,536 |
| ST6GAL1_2 ↗ | 3:187,021,855 | 正股 | 187,021,806–187,021,865 |
| ST6GAL1_3 ↗ | 3:187,025,483 | 正股 | 187,025,434–187,025,493 |
EPDnew human v006 · UCSC hg38,GRCh38/hg38,透過 UCSC 取得。TSS 具有 CAGE/RAMPAGE 等實驗資料支持;任意擷取的上下游區間仍需另行判讀調控功能,不能視為整段皆經功能驗證。
EPD 封存狀態 ↗ · UCSC 資料說明 ↗ · EPD team, SIB Swiss Institute of Bioinformatics; UCSC Genome Browser · CC BY 4.0
蛋白質結構域與序列
參考蛋白質長度:406 aa
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 長 406 個胺基酸,屬於 glycosyltransferase 29 家族。其 N 端第 1–9 位為細胞質區,第 10–26 位為螺旋狀跨膜區,並作為第二型膜蛋白的訊號錨定區;第 27–406 位位於腔內。
蛋白質三維結構
細胞內定位
ST6GAL1 的膜結合型位於高基氏體 trans cisternae,並與 MGAT3、B4GALT1 在高基氏體堆疊中共定位,包括其 cis 區域。 另有資料指出,該蛋白可分泌至體液中;此分泌定位屬於相似性推論。
深綠色圓點:來源記載的蛋白質定位;數量不表示含量。
細胞外定位:圓點散佈於細胞周圍,與細胞膜保持距離。
動物細胞結構示意;器官大小與數量不按比例。點選細胞構造可查看定位註解。
交互作用與訊號網絡
拖曳節點後放開可帶動位置變化;點選夥伴查看證據。位置與連線長度不代表結合強度,圖中未推定夥伴彼此之間的關係。
ST6GAL1 可呈單體或同源二聚體形式。來源未提供其與其他蛋白質形成實體結合或複合體的資訊。
疾病與遺傳關聯
Contextual Functional Evidence Matrix
矩陣以「功能主張」為列,以細胞情境、干預條件、量測結果與證據來源為欄,方便比較同一功能在不同條件下的支持情形。只有含情境與實驗資訊的紀錄會列入矩陣;一般功能註解另列於下方。
功能註解總覽 · 14 筆
| 功能面向 | 功能敘述 | 證據類型 | 可查核來源 |
|---|---|---|---|
| 功能 | ST6GAL1 將唾液酸由 CMP-sialic acid 轉移至含半乳糖的受體。在 B 淋巴球中,這項作用會生成對 neuraminidase 敏感的細胞表面分化抗原,包括 CDw75、HB-6 與 CD76。它也會唾液酸化 IgG 的 Fc 區複合型 N-醣鏈,賦予抗發炎效應功能;在 Fc 醣鏈上,優先修飾 alpha(1->3) mannose 分枝形成單唾液酸化產物,之後形成雙唾液酸化產物的速度較慢。 | 含實驗來源 | 證據與來源Transfers sialic acid from CMP-sialic acid to galactose-containing acceptor substrates. In B lymphocytes, generates neuraminidase-sensitive lymphocyte cell-surface differentiation antigens, such as CDw75, HB-6 and CD76. Sialylates complex-type N-glycans attached on the fragment crystallizable (Fc) of IgGs conferring anti-inflammatory effector functions. Preferentially monosialylates the alpha(1->3) mannose antenna of Fc glycoforms with subsequent disialylation occurring at a much slower rate PMID 1730763 ↗ · PMID 21081508 ↗ · PMID 23999306 ↗ · PMID 25733881 ↗ · PMID 27872474 ↗ · PMID 36280670 ↗ · PMID 37632720 ↗ |
| 分子活性 | a beta-D-galactoside + CMP-N-acetyl-beta-neuraminate = an N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl derivative + CMP + H(+) | 含實驗來源 | 證據與來源a beta-D-galactoside + CMP-N-acetyl-beta-neuraminate = an N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl derivative + CMP + H(+) PMID 21081508 ↗ · PMID 23999306 ↗ · PMID 25733881 ↗ · PMID 36280670 ↗ · PMID 37632720 ↗ |
| 分子活性 | an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 25733881 ↗ · PMID 37632720 ↗ |
| 分子活性 | an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 25733881 ↗ · PMID 37632720 ↗ |
| 分子活性 | an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 37632720 ↗ |
| 分子活性 | an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 36280670 ↗ |
| 分子活性 | an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 36280670 ↗ |
| 分子活性 | an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 37632720 ↗ |
| 分子活性 | an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 36280670 ↗ · PMID 37632720 ↗ |
| 分子活性 | an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 37632720 ↗ |
| 分子活性 | an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) | 含實驗來源 | 證據與來源an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP-N-acetyl-beta-neuraminate = an N(4)-{alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->4)]-[alpha-Neu5Ac-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-[alpha-L-Fuc-(1->6)]-beta-D-GlcNAc}-L-asparaginyl-[protein] + CMP + H(+) PMID 36280670 ↗ |
| 分子活性 | ST6GAL1 參與蛋白質修飾,具體類別為蛋白質醣基化。 | 資料庫紀錄 | |
| 交互作用 | ST6GAL1 可呈現單體形式,也可形成同源二聚體。 | 含實驗來源 | |
| 細胞定位 | ST6GAL1 是單次穿膜的第二型膜蛋白,膜結合型位於高基氏體 trans cisternae;另有相似性推論指出它可分泌至體液。ST6GAL1 也與 MGAT3 和 B4GALT1 在高基氏體堆疊中共定位,涵蓋 cis 區域。 | 含實驗來源 | 證據與來源Golgi apparatus, Golgi stack membrane / Single-pass type II membrane protein; Secreted; Membrane-bound form in trans cisternae of Golgi. Secreted into the body fluid (By similarity). Colocalizes with MGAT3 and B4GALT1 in the Golgi stacks of cisternae, including the cis-part of the Golgi stacks PMID 1730763 ↗ · PMID 20378551 ↗ · PMID 29133956 ↗ |
核酸與蛋白質序列
GCTCTTCTTCCTTCCTTCTCCAGTCCCTTCCACTGTGCGT40CTTCTGTCCCCCGTTCTTCCCCAGCGGACCCCTCTTTCGA80GACTCCCTAGTGGGGTCCCCAGCTCCCGGGCGATCCTGCC120CTTGCCGAGCGCGTTTTCTGGAGTCACCTGGGGGAGGGGA160GTCCTGGGCAGGGCCGGGCTGGGGAAGACGCCTGGGGCAC200TGCCCGGCGTTAACAAAGGGAGCCGATACCGACCGGCGTG240GGCGCGGAGCGGGCGGCCGCCACCGAGCGTGCTGAGCAAC280CGCAGCCTCCGCGGCCGAGAGTGCAGCGAGCAAGGGGAGA320GCCAGTTGCGCAGAGCCCTGCAACCAGCAGTCCAGGGAGA360AGTGGTGAATGTCATGGAGCCCAGCTGAAATGGACTGGCC400CCCTTGAGCCTGTCCCAAGCCCTGGTGCCAGGTGTCCATC440CCCGTGCTGAGATGAGTTTTGATCATCCTGAGAAAAATGG480GCCTTGGCCTGCAGACCCAATAAACCTTCCCTCCCATGGA520TAATAGTGCTAATTCCTGAGGACCTGAAGGGCCTGCCGCC560CCTGGGGGATTAGCCAGAAGCAGGCTTGTTTTCCTGCTCA600GAACAAAGTGACTTCCCTGAACACATCTTCATTATGATTC640ACACCAACCTGAAGAAAAAGTTCAGCTGCTGCGTCCTGGT680CTTTCTTCTGTTTGCAGTCATCTGTGTGTGGAAGGAAAAG720AAGAAAGGGAGTTACTATGATTCCTTTAAATTGCAAACCA760AGGAATTCCAGGTGTTAAAGAGTCTGGGGAAATTGGCCAT800GGGGTCTGATTCCCAGTCTGTATCCTCAAGCAGCACCCAG840GACCCCCACAGGGGCCGCCAGACCCTCGGCAGTCTCAGAG880GCCTAGCCAAGGCCAAACCAGAGGCCTCCTTCCAGGTGTG920GAACAAGGACAGCTCTTCCAAAAACCTTATCCCTAGGCTG960cDNA 使用 DNA 字母 T;mRNA 模式改以 U 顯示。轉錄本保留已註解的非編碼區,未另外加入 poly(A) 尾;非編碼 RNA 的參考轉錄本也可能仍需後續加工。數字為所選序列的 1-based 位置。長序列以黃色捲軸瀏覽,可複製或下載完整轉錄本與蛋白質;基因組 DNA 隨捲動取得所需範圍。